Solar Biotech, a pioneering technology and bioproducts development company, has successfully raised $15 million in funding. The company specializes in utilizing biological systems and cutting-edge biomanufacturing technologies to produce SynBio products through precision fermentation and advanced downstream processing. While Solar Biotech is not a traditional solar power firm, it aims to revolutionize the SynBio market segments, particularly focusing on SynBio FoodTech. The significant funding infusion will enable Solar Biotech to further its mission of becoming a global leader in sustainable microbial cell-based biomanufacturing technologies and services. With a strong commitment to sustainability and delivering top-tier SynBio products that meet the demand for traceable, healthier, and safer consumer goods, Solar Biotech is well-positioned to make a lasting impact on the global market.







